Combined therapy with estrogen and etidronate has an additive effect on bone mineral density in the hip and vertebrae: Four-year randomized study

Am J Med. 2024 Jul;137(7):683. doi: 10.1016/j.amjmed.2024.03.008. Epub 2024 Mar 22.
No abstract available

Publication types

  • Randomized Controlled Trial
  • Letter
  • Expression of Concern

MeSH terms

  • Aged
  • Bone Density Conservation Agents* / therapeutic use
  • Bone Density* / drug effects
  • Drug Therapy, Combination
  • Estrogens / administration & dosage
  • Etidronic Acid* / therapeutic use
  • Female
  • Humans
  • Lumbar Vertebrae
  • Middle Aged
  • Osteoporosis, Postmenopausal / drug therapy

Substances

  • Bone Density Conservation Agents
  • Estrogens
  • Etidronic Acid